Calcium glycerophosphate is the Latin name for a drug whose active chemical substance is the calcium salt of 1,2,3-propanetriol mono (dihydrogen phosphate). Calcium glycerophosphate has a CAS code (registration in the Chemical Abstracts Service registry) - 27214-00-2. It is produced by the Lugansk HFZ in cardboard boxes with one or two non-cell contour packs, each containing 10 tablets containing 200 mg of active ingredient. The company Veropharm (Russia, Belgorod) produces tablets with an active substance content of 0.5 g (500 mg), also in non-cell contour packaging, 10 tablets each. It is used to regulate the exchange of phosphorus and calcium, as well as a tonic and restorative agent that can stimulate metabolic processes in the body.
The preparation contains calcium and phosphorus - very important mineral elements. Due to its chemical composition, it is important for the health of bones and teeth, since bones and teeth are largely composed of calcium phosphate and its derivatives. The bioavailability of calcium is incomparably higher than in another calcium-containing preparation "Pantocalcin" (has a nootropic effect) or, as it is also called, calcium hopantenate. The manufacturer's instructions contain information that Calcium glycerophosphate is available over-the-counter. Due to the good digestibility of calcium and phosphorus in the food industry, it is used as a food supplement E383.
The basis for the use of the drug are diseases such as dystrophy, hypocalcemia (in the blood serum, the content of calcium ions is reduced), rickets (a disease of infants associated with impaired bone formation due to calcium deficiency), as well as with a reduced general body resistance (nervous exhaustion, overwork, malnutrition). It is allowed to prescribe the drug to pregnant and lactating women. One of the most famous and described indications when a doctor prescribes calcium glycerophosphate is problems associated with interstitial cystitis, which lead to frequent urination and poor control of the bladder due to its chronic inflammation or the use of acidic foods.
Studies have shown that calcium glycerophosphate can significantly reduce the urge to urinate, as well as minimize the discomfort that people experience after consuming strongly acidic foods (tomatoes, fruit juices). An analogue of this drug, manufactured by AkPharma, has the trade name "Prelief". Each tablet contains 345 mg of calcium glycerophosphate (65 mg of elemental calcium). 0.25% magnesium stearate is also included in the drug (as a processing aid). Two tablets are equivalent to 690 mg of calcium glycerophosphate (130 mg of elemental calcium).
You can use calcium glycerophosphate after medical advice. Self-medication can cause serious disorders in the body. Allergic reactions are possible, and there are also contraindications to its use. These include: hypercalcemia (increased plasma concentration of calcium), hypersensitivity (to calcium, phosphorus or glycerin and its derivatives), thrombosis (the formation of blood clots in the lumen of blood vessels), thrombophlebitis (thrombosis aggravated by inflammation of the vessel walls), as well as early children's age (up to two years). With prolonged use, there is a risk of a decrease in the acidity of the stomach due to a decrease in the normal level of hydrochloric acid in it, which is necessary for the digestion process. Therefore, experts recommend limiting the unreasonable intake of this medication.
Take calcium glycerophosphate orally 2 to 3 times a day. Adults are prescribed to take at one time from 200 mg (1 tablet Veropharm) to 500 mg (2.5 tablets Veropharm). For children over two years of age, you can take from 50 mg (¼ tablets of Veropharm) to 200 mg (1 tablet of Veropharm). It is recommended for complex therapy with iron preparations. Accepted regardless of food intake and from foods included in the diet. It should be recalled that this article is not a substitute for medical advice; it is intended to prevent self-medication.